C BMI 27 vi cc tnh trng lin quan n cn nng (v d: khng insulin, cholesterol cao) B khng insulin hoc tin tiu ng Nn chn chng trnh gim cn c s gim st y t
They can support weight loss while also helping you avoid some common GLP-1 side effects like constipation, nausea, fatigue, and muscle loss
She thinks we need an over-the-counter GLP-1 to really make a dent in the obesity epidemic, and while most of her colleagues would balk at that (as I did), her reasoning is hard to argue with
Sources MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Lilly Launches Additional Zepbound Vial Doses and Offers New Savings for Self-Pay Patients (February 25, 2025) LillyDirect: Zepbound (Accessed: May 21, 2025) Savings & Support for Mounjaro (Accessed: May 21, 2025) Medicare Coverage of GLP-1 Drugs (Accessed: May 21, 2025)
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
